東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Multiple myeloma and other plasma ce...

Dimopoulos, Meletios A.

Linked to FindBook

Google Book

Amazon

博客來

Multiple myeloma and other plasma cell neoplasms

Record Type:	Electronic resources : Monograph/item
Title/Author:	Multiple myeloma and other plasma cell neoplasms/ edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
other author:	Dimopoulos, Meletios A.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	vi, 245 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Multiple myeloma. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-25586-6
ISBN:	9783319255866

Multiple myeloma and other plasma cell neoplasms
Multiple myeloma and other plasma cell neoplasms[electronic resource] /edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos. - Cham :Springer International Publishing :2018. - vi, 245 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenstrom's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.

ISBN: 9783319255866

Standard No.: 10.1007/978-3-319-25586-6doiSubjects--Topical Terms:

864788
Multiple myeloma.

LC Class. No.: RC280.B6

Dewey Class. No.: 616.99418

Multiple myeloma and other plasma cell neoplasms
LDR:02113nmm a2200313 a 4500 001 2134106
003 DE-He213
005 20180216105137.0
006 m d
007 cr nn 008maaau
008 181005s2018 gw s 0 eng d
020 $a 9783319255866 $q (electronic bk.)
020 $a 9783319255842 $q (paper)
024 7 $a 10.1007/978-3-319-25586-6 $2 doi
035 $a 978-3-319-25586-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B6
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
082 0 4 $a 616.99418 $2 23
090 $a RC280.B6 $b M961 2018
245 0 0 $a Multiple myeloma and other plasma cell neoplasms $h [electronic resource] / $c edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a vi, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
520 $a This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenstrom's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.
650 0 $a Multiple myeloma. $3 864788
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Hematology. $3 808260
650 2 4 $a Oncology. $3 751006
650 2 4 $a Immunology. $3 611031
700 1 $a Dimopoulos, Meletios A. $3 3302247
700 1 $a Facon, Thierry. $3 3302248
700 1 $a Terpos, Evangelos. $3 3302249
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 1568109
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-25586-6
950 $a Medicine (Springer-11650)